Skip to content

Clinical and Radiographic Assessment of Neo Putty MTA Versus Formocresol Used in Vital Pulpotomy of Mandibular Primary Molars

Clinical and Radiographic Assessment of Neo Putty MTA Versus Formocresol Used in Vital Pulpotomy of Mandibular Primary Molars: A Randomized Clinical Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07437794
Enrollment
68
Registered
2026-02-27
Start date
2026-03-01
Completion date
2026-05-01
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Caries in Primary Molars

Keywords

Deep Caries in Primary Molars, NeoPutty MTA, Mineral Trioxide Aggregate, Formocresol, Vital Pulp Therapy, Pulpotomy, Stainless Steel Crown

Brief summary

This randomized clinical trial aims to evaluate the clinical and radiographic success of NeoPutty MTA compared to formocresol in vital pulpotomy of mandibular primary molars in children aged 4 to 9 years. Participants will be randomly allocated into two groups (1:1) to receive pulpotomy using either NeoPutty MTA or formocresol, followed by restoration with stainless steel crowns. Clinical and radiographic outcomes will be assessed during follow-up visits.

Detailed description

Pulpotomy is a commonly performed vital pulp therapy in pediatric dentistry. Formocresol has been widely used due to its high clinical success; however, concerns exist regarding its potential toxicity. NeoPutty MTA is a premixed bioceramic material introduced as an alternative pulpotomy agent with improved handling properties and bioactivity. This randomized parallel-group clinical trial will compare NeoPutty MTA versus formocresol in vital pulpotomy of mandibular primary molars. Children aged 4-9 years presenting with asymptomatic carious mandibular primary molars will be recruited from the Pediatric Dentistry Department, Faculty of Dentistry, MSA University. Eligible teeth will undergo standardized pulpotomy procedures, restoration with glass ionomer cement, and stainless steel crowns. Clinical and radiographic follow-up will be performed at scheduled intervals to evaluate success and failure outcomes.

Interventions

NeoPutty MTA (NuSmile) will be placed directly over the radicular pulp stumps after hemostasis, then the tooth will be sealed with resin-modified glass ionomer cement and restored with stainless steel crown.

A sterile cotton pellet lightly moistened with a 1:5 dilution of Buckley's formocresol will be placed against the pulp stumps for 3-5 minutes, then removed. Reinforced zinc oxide eugenol will be placed, followed by glass ionomer cement and stainless steel crown restoration.

Sponsors

October University for Modern Sciences and Arts
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

the statistician will be blinded

Eligibility

Sex/Gender
ALL
Age
4 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

Children with asymptomatic decayed primary mandibular molar(s). * Patient and parent showing cooperation and compliance. * Children 4-9 years old. * Vital carious primary(s) with complete root formation. * Asymptomatic teeth or without clinical symptoms of spontaneous pain. * No clinical evidence of pulp degeneration like the history of spontaneous or nocturnal pain, tenderness to percussion, pathologic tooth mobility, swelling, or fistulous tract. * Both genders will be included. * No radiographic evidence of pulp degeneration such as internal root resorption, external root resorption, or furcal radiolucency. * Presence of two thirds of the root. * Teeth that can be restored. * Children with prior parental consent.

Exclusion criteria

* History of any systemic disease. * Hemostasis is not achieved within 5 minutes of pulp amputation, by direct contact with a wet cotton pellet before the material placement. * The remaining radicular tissue was non-vital (with suppuration or purulence necrosis).

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain1 week postoperatively, 3 months, 6 months, 9 months and 12 monthsPresence or absence of spontaneous postoperative pain reported by the child/parent after pulpotomy treatment.

Secondary

MeasureTime frameDescription
Pain on percussion3 months, 6 months, 9 months and 12 monthsDescription: Presence or absence of pain on percussion during clinical follow-up visits.
Presence of sinus tract, fistula or abscess3 months, 6 months, 9 months and 12 monthsDescription: Clinical evaluation for presence of swelling, abscess, or sinus/fistulous tract related to the treated tooth.
Tooth mobility3 months, 6 months, 9 months and 12 monthsDescription: Tooth mobility assessed clinically using a mobility scoring system ranges from 0-3 were (score 0 the best) indicates no mobility and (score 3 the worst) indicates vertical and horizontal mobility.
Widening of Periodontal Ligament Space6 months and 12 months after treatmentRadiographic evidence of widening of the periodontal ligament space assessed using standardized periapical radiographs. Recorded as Present / Absent.
Internal and External Root Resorption6 months and 12 months after treatmentRadiographic evidence of internal or external root resorption observed on periapical radiographs. Recorded as Present / Absent.
Furcal or Periapical Radiolucency6 months and 12 months after treatmentPresence of radiolucent lesion in the furcation or periapical area detected on standardized periapical radiographs. Recorded as Present / Absent.

Countries

Egypt

Contacts

CONTACTAhmed Shawky, bachelor of dentistry
ahmed.shawky3@msa.edu.eg+201124465202

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026